Toth Financial Advisory Corp Purchases 4,074 Shares of The Clorox Company (NYSE:CLX)

Toth Financial Advisory Corp grew its holdings in shares of The Clorox Company (NYSE:CLX) by 36.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,177 shares of the company’s stock after purchasing an additional 4,074 shares during the quarter. Toth Financial Advisory Corp’s holdings in Clorox were worth $2,465,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter worth $27,000. Continuum Advisory LLC raised its holdings in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Quarry LP raised its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new position in Clorox in the 3rd quarter worth $48,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.1 %

Shares of NYSE:CLX opened at $159.12 on Friday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The business has a 50 day simple moving average of $163.66 and a two-hundred day simple moving average of $157.32. The firm has a market capitalization of $19.70 billion, a PE ratio of 55.44, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.49 earnings per share. On average, equities analysts predict that The Clorox Company will post 6.87 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. Clorox’s payout ratio is 170.04%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CLX shares. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and increased their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.